INM

InMed Pharmaceuticals Inc. is a Vancouver-based clinical-stage biopharmaceutical company focused on the innovative development of cannabinoid-based therapies for various medical conditions. The firm leverages its proprietary biosynthesis technology to produce pharmaceutical-grade cannabinoids, targeting significant unmet medical needs in the healthcare landscape. With a robust pipeline of drug candidates progressing through clinical trials, InMed is well-positioned to capitalize on the growing global demand for cannabinoid therapies, thereby contributing to advancements in cannabinoid medicine and enhancing patient care.